Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization

Journal of Experimental & Clinical Cancer Research(2021)10.1186/s13046-021-01985-9Source: DataRank Database

Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization is a research paper published in Journal of Experimental & Clinical Cancer Research (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.88)OA: goldTopics (83)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Debarshi Roy ORCID,Ling Jin ORCID,Prabhu Thirusangu ORCID,Julie K. Staub ORCID,Yinan Xiao ORCID

Live enrichment

PubMed:34082797 PMC:PMC8173968 OpenAlex:https://openalex.org/W3165178673

National Institutes of Health

Grant: P50CA136393

National Institutes of Health

Grant: 5P50CA136393-10

Mayo Clinic Ovarian Cancer SPORE

FWCI

2.88

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://jeccr.biomedcentral.com/track/pdf/10.1186/s13046-021-01985-9

GOLDhttps://jeccr.biomedcentral.com/track/pdf/10.1186/s13046-021-01985-9

publisherhttps://jeccr.biomedcentral.com/track/pdf/10.1186/s13046-021-01985-9

publisherhttps://link.springer.com/content/pdf/10.1186/s13046-021-01985-9.pdf

publisherhttps://link.springer.com/article/10.1186/s13046-021-01985-9/fulltext.html

Fields of Study

Lipid metabolism and biosynthesisCancer, Lipids, and MetabolismAutophagy in Disease and TherapyMedicineBiology0301 basic medicine03 medical and health sciencesAnimalsAutophagyCRISPR-Cas SystemsCell ProliferationCell SurvivalFemaleGene Expression Regulation, NeoplasticGroup III Phospholipases A2HeterograftsHumansLipid DropletsLipogenesisMiceMicroscopy, Electron, TransmissionNeoplasm MetastasisOvarian NeoplasmsPlatinumPyridinesQuinolines

MeSH Terms

AnimalsAutophagyCell SurvivalFemaleHumansNeoplasm MetastasisOvarian NeoplasmsPlatinumPyridinesQuinolinesGene Expression Regulation, NeoplasticMicroscopy, Electron, TransmissionCell ProliferationLipogenesisMiceGroup III Phospholipases A2CRISPR-Cas SystemsHeterograftsLipid Droplets

Keywords

SensitizationDownregulation and upregulationMetastasisMedicineOncologyCancer researchOvarian cancerApoptosisCancerInternal medicineBiologyImmunologyGenechemosensitivityAutophagyprimary ciliaGroup Iii Phospholipase A2Cell SurvivalPyridinesMiceMicroscopy, Electron, TransmissionAnimalsHumansNeoplasm MetastasisRC254-282Cell ProliferationPlatinumOvarian NeoplasmsResearchGroup III Phospholipases A2LipogenesisNeoplasms. Tumors. Oncology. Including cancer and carcinogensLipid DropletsGene Expression Regulation, NeoplasticQuinolinesHeterograftsFemaleCRISPR-Cas Systems

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization

10.6084/m9.figshare.14728585.v1figshare

Additional file 1 of Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization

10.6084/m9.figshare.14728585figshare

Additional file 2 of Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma

10.6084/m9.figshare.24804814.v1figshare

Additional file 2 of Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma

10.6084/m9.figshare.24804814figshare

Additional file 1 of Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma

10.6084/m9.figshare.24804286.v1figshare

Additional file 1 of Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma

10.6084/m9.figshare.24804286figshare

Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization

10.6084/m9.figshare.c.5451826figshare

Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization

10.6084/m9.figshare.c.5451826.v1figshare